Predicting 1p/19q chromosomal deletion of brain tumors using machine learning


Cinarer G., Emiroǧlu B. G., Yurttakal A. H.

Emerging Materials Research, cilt.10, sa.2, ss.238-244, 2021 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 10 Sayı: 2
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1680/jemmr.20.00350
  • Dergi Adı: Emerging Materials Research
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.238-244
  • Anahtar Kelimeler: computational studies, imaging, processing, LOW-GRADE GLIOMAS, MRI
  • Yozgat Bozok Üniversitesi Adresli: Evet

Özet

© 2021 ICE Publishing: All rights reserved.Advances in molecular and genetic technologies have enabled the study of mutation and molecular changes in gliomas. The 1p/19q coding state of gliomas is important in predicting pathogenesis-based pharmacological treatments and determining innovative immunotherapeutic strategies. In this study, T1-weighted and T2-weighted fluid-attenuated inversion recovery magnetic resonance imaging (MRI) images of 121 low-grade glioma patients with biopsy-proven 1p/19q coding status and no deletion (n = 40) or co-deletion (n = 81) were used. First, regions of interests were segmented with the grow-cut algorithm. Later, 851 radiomic features including three-dimensional wavelet preprocessed and non-preprocessed ones were extracted from six different matrices such as first order, shape and texture. The extracted features were preprocessed with the synthetic minority over-sampling technique algorithm. Next, the 1p/19q decoding states of gliomas were classified using machine-learning algorithms. The best classification in the classification of glioma grades (grade II and grade III) according to 1p/19q coding status was obtained by using the logistic regression algorithm, with 93.94% accuracy and 94.74% area under the curve values. In conclusion, it was determined that non-invasive estimation of 1p/19q status from MRI images enables the selection of effective treatment strategies with early diagnosis using machine-learning algorithms without the need for surgical biopsy.